Vimarsana
Biggest News Aggregation in the World

Injectable Formulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Injectable Formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Injectable Formulation Today - Breaking & Trending Today

Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria - Vimarsana News

Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria

Published: April 8, 2024

MONTPELLIER, France, April 08, 2024--Regulatory News: Global health agency Unitaid has awarded Medincell (Paris:MEDCL) an extension grant of up to US$ 6 million over three years to fund the clinical phase 1 activities of long-acting injectable mdc-STM. If proven safe, effective, and acceptable, mdc-STM could have a significant impact on transmission of malaria among vulnerable populations in high-transmission areas.

Source: yahoo.com
Related Topics:
United StatesChristophe DouatDavid HeuzTeva PharmaceuticalsFinancial CommunicationsHead Of Global Health Development At MedincellRegulatory NewsGlobal Health DevelopmentMalaria ReportGlobal Technical StrategyMedicines Patent PoolDes MarchGlobal HealthMalaria TransmissionSubcutaneous InjectionInjectable Formulation
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024 - Vimarsana News

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

Published: April 6, 2024

PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable formulation of risperidone microspheres Additional UZEDY...

Source: marketscreener.com
Related Topics:
United StatesPharmacokinetic PopEric HughesDrug AdministrationTeva PharmaceuticalsPopulation Pharmacokinetic Modeling Following Administration Of OlanzapineMental Health Services AdministrationTeva Neuroscience IncInternational Survey Study To Assess The PerceptionsNational Pregnancy Registry For Atypical AntipsychoticsTeva Pharmaceutical Industries LtdInternational Survey Assessing The PerceptionsSchizophrenia International Research SocietyTeva Pharmaceutical IndustriesExecutive Vice PresidentChief Medical OfficerRisperidone Subcutaneous Extended Release StudyAttitudes Driving Regional DifferencesSchizophrenia Among Healthcare ProfessionalsOccupational ImpactTardive DyskinesiaInternational Survey AssessingPatients WithPhysicians Who TreatInternational Survey Study